Search Within

Shakeel Modak

  1. "2011"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
Groups
  1. Neuroblastoma Service (6)
  2. Pediatrics, Department of (6)
  3. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (5)
  5. GSK Faculty (5)
  6. Tow Center for Developmental Oncology (TCDO) (5)

More Groups

People
  1. Nai-Kong Cheung (5)
  2. Brian Kushner (4)
  3. Kim Kramer (4)
  4. Bo Dupont (1)
  5. Irene Cheung (1)
  6. Jeffrey Venstrom (1)

More People

Years
  1. 2011 (6)
Publications
  1. Pediatric Blood and Cancer (3)
  2. Clinical Advances in Hematology & Oncology (1)
  3. European Journal of Cancer (1)
  4. Journal of Clinical Oncology (1)
Publishers
  1. Wiley Periodicals, Inc (3)
  2. American Society of Clinical Oncology (1)
  3. Elsevier Inc. (1)
  4. Millennium Medical Publishing, Inc (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combined anti-angiogenesis and radioimmunotherapy for neuroblastoma: Results of a phase I study
    Meeting Abstract

    Modak, S.; Kushner, B.; Kramer, K.; Cheung, N. K.
    Pediatric Blood and Cancer (2011)

    Fulltext@MSK | Save
  • KIR/HLA genotypes predictive of missing KIR ligands are associated with improved outcome in patients with high-risk neuroblastoma treated with anti-GD2 monoclonal antibody therapy
    Meeting Abstract

    Gallagher, M.; Tarek, N.; Zheng, J. T.; Venstrom, J. M.; Cheung, I. Y.; Modak, S.; Dupont, B.; Cheung, N. K. V.; Hsu, K. C.
    Pediatric Blood and Cancer (2011)

    Fulltext@MSK | Save
  • Successful multifold dose escalation of anti-GD2 monoclonal antibody 3F8 in patients with neuroblastoma: A phase I study
    Journal Article

    Kushner, B. H.; Kramer, K.; Modak, S.; Cheung, N. K. V.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Updates in the treatment of neuroblastoma
    Journal Article

    Modak, S.
    Clinical Advances in Hematology & Oncology (2011)

    Fulltext@MSK | Save
  • High-dose cyclophosphamide-irinotecan-vincristine for primary refractory neuroblastoma
    Journal Article

    Kushner, B. H.; Kramer, K.; Modak, S.; Yataghene, K.; Cheung, N. K. V.
    European Journal of Cancer (2011)

    Fulltext@MSK | Save
  • High-dose carboplatin-irinotecan-temozolomide: Treatment option for neuroblastoma resistant to topotecan
    Journal Article

    Kushner, B. H.; Kramer, K.; Modak, S.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2011)

    Fulltext@MSK | Save